Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Conmed (CNMD) EBT Margin (2016 - 2026)

Conmed filings provide 17 years of EBT Margin readings, the most recent being 5.79% for Q1 2026.

  • On a quarterly basis, EBT Margin rose 340.0% to 5.79% in Q1 2026 year-over-year; TTM through Mar 2026 was 5.97%, a 507.0% decrease, with the full-year FY2025 number at 5.17%, down 730.0% from a year prior.
  • EBT Margin hit 5.79% in Q1 2026 for Conmed, down from 7.84% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 17.83% in Q3 2024 to a low of 33.72% in Q2 2022.
  • Median EBT Margin over the past 5 years was 6.66% (2023), compared with a mean of 4.49%.
  • Biggest five-year swings in EBT Margin: crashed -4011bps in 2022 and later skyrocketed 3921bps in 2023.
  • Conmed's EBT Margin stood at 4.2% in 2022, then soared by 396bps to 12.44% in 2023, then grew by 1bps to 12.62% in 2024, then tumbled by -38bps to 7.84% in 2025, then decreased by -26bps to 5.79% in 2026.
  • The last three reported values for EBT Margin were 5.79% (Q1 2026), 7.84% (Q4 2025), and 1.26% (Q3 2025) per Business Quant data.